WA1
NVO

Wimmer Associates 1’s Novo Nordisk NVO Stock Holding History

Wimmer Associates 1’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-4,425
Closed -$246K – 110
2025
Q3 		$246K Hold
4,425
– – 0.12% 101
2025
Q2 		$305K Hold
4,425
– – 0.16% 94
2025
Q1 		$289K Sell
4,425
-360
-8% -$29.7K 0.15% 95
2024
Q4 		$412K Sell
4,785
-1,690
-26% -$183K 0.2% 79
2024
Q3 		$771K Buy
6,475
+160
+3% +$21.3K 0.38% 61
2024
Q2 		$901K Hold
6,315
– – 0.46% 51
2024
Q1 		$811K Buy
6,315
+35
+0.6% +$4.17K 0.43% 58
2023
Q4 		$650K Buy
6,280
+1,530
+32% +$151K 0.37% 66
2023
Q3 		$432K Buy
4,750
+850
+22% +$74.9K 0.27% 80
2023
Q2 		$316K Buy
3,900
+100
+3% +$8.17K 0.19% 91
2023
Q1 		$322K Hold
3,800
– – 0.21% 88
2022
Q4 		$257K Sell
3,800
-380
-9% -$22.3K 0.17% 98
2022
Q3 		$227K Hold
4,180
– – 0.15% 104
2022
Q2 		$233K Sell
4,180
-350
-8% -$19.4K 0.15% 102
2022
Q1 		$252K Buy
+4,530
New +$232K 0.14% 108
2017
Q1 		– Sell
-68,940
Closed -$1.24M – 112
2016
Q4 		$1.24M Sell
68,940
-21,090
-23% -$382K 1.15% 36
2016
Q3 		$1.87M Sell
90,030
-1,570
-2% -$38.9K 1.69% 18
2016
Q2 		$2.46M Sell
91,600
-90
-0.1% -$2.47K 2.2% 9
2016
Q1 		$2.48M Buy
91,690
+3,280
+4% +$87.9K 2.28% 9
2015
Q4 		$2.57M Buy
+88,410
New +$2.45M 2.69% 3

Other funds holding NVO

Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wimmer Associates 1's NVO Position: Q4 2025 in Review

Wimmer Associates 1 sold out of Novo Nordisk (NVO) in Q4 2025, closing a stake of 4,425 shares — an estimated $246K sold.

Wimmer Associates 1 first reported a position in NVO in Q4 2015 and held it in 20 quarters. The position peaked at $2.57M in Q4 2015. 1,413 funds tracked by Wall St. Rank hold NVO as of Q4 2025.

  • Wimmer Associates 1 reported no remaining Novo Nordisk position as of Q4 2025 after selling out during the quarter.
  • Wimmer Associates 1 sold 4,425 Novo Nordisk shares in Q4 2025, an estimated $246K.
  • Wimmer Associates 1 first reported a position in Novo Nordisk in Q4 2015 and held it in 20 quarters.
  • Wimmer Associates 1's Novo Nordisk position peaked at $2.57M in Q4 2015.
  • 1,413 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2025.

Based on Wimmer Associates 1's 13F filing for Q4 2025, filed 13 Feb 2026.